Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review
| dc.contributor.author | Nokuthula L, Makhene, | |
| dc.contributor.author | Steyn, Hanlie | |
| dc.contributor.author | Vorster, Martine | |
| dc.contributor.author | Lubbe, Martie S | |
| dc.contributor.author | Burger, Johanita R. | |
| dc.date.accessioned | 2023-05-04T10:03:15Z | |
| dc.date.available | 2023-05-04T10:03:15Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Introduction: National regulatory systems in Southern Africa reflect various stages of maturity, and pharmacovigilance (PV) practices are not aligned. In the absence of guidance for formulating PV guidelines in Southern African Development Community (SADC) countries, this study aimed to create a checklist that may be used to assess the rigour of PV guidelines in this region and provide guidance for the National Medicines Regulatory Agency (NMRA) authors. Methods: A document analysis was performed based on harmonised international guidelines (n=22) that prescribed methods of PV regulation to identify themes and items to incorporate into a checklist. The contextualisation of the checklist to the African pharmaceutical environment was accomplished by referencing peer-reviewed journal articles (n=7). The checklist was subjected to face and content validation by non-experts and PV experts. Results: The document review yielded 5 themes, 18 sub-themes, and 73 items structured into the checklist. Themes encompassed PV systems, definitions, individual case safety reporting, aggregate reporting, and risk management. Under PV systems, aspects of the quality management system were outlined, that is, the legal basis for PV, a description of the marketing authorisation holder's (MAH's) PV system, archiving of data, contracting of PV tasks, and the duties of the person responsible for the MAH's PV obligations. Definitions of the key terms and major stakeholders were identified. Reporting of individual case safety reports (ICSRs) was explicated by considering the criteria for reporting, categories of reportable information, expedited reporting requirements, reporting timelines, and ICSR reporting format. Aggregate report submission during the development and post-marketing phases was addressed. Risk management encompassed signal detection, re-evaluation of the benefit-risk ratio, the safety decision-making process, risk management planning, risk minimisation and safety communication. Conclusion: The developed checklist can contribute towards assisting SADC NMRAs to formulate national PV guidelines that reflect current international practice, with local context incorporated. | en_US |
| dc.identifier.citation | Nokuthula L. Makhene, Hanlie Steyn, Martine Vorster, Martie S. Lubbe and Johanita R. Burger. 2023. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.https://doi.org/10.1177/20420986221143272 | en_US |
| dc.identifier.uri | https://doi.org/10.1177/20420986221143272 | |
| dc.identifier.uri | http://hdl.handle.net/10394/41228 | |
| dc.language.iso | en | en_US |
| dc.publisher | Sage | en_US |
| dc.subject | checklist | en_US |
| dc.subject | document analysis | en_US |
| dc.subject | guidelines | en_US |
| dc.subject | pharmacovigilance | en_US |
| dc.subject | Southern African Development Community | en_US |
| dc.title | Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Nokuthula L. Makhene_ Development of a checklist.pdf
- Size:
- 909.57 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.61 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
